Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Suctioning the Oropharyngeal Airway01:25

Suctioning the Oropharyngeal Airway

875
In preparing for oropharyngeal airway suctioning, a nurse must gather all necessary equipment, including a suction unit with tubing, a prepackaged suction kit, sterile gloves, water or saline for irrigation, a water-soluble lubricant, and additional personal protective equipment (such as a gown, mask, and goggles) to control infections.
After assembling the equipment, the nurse should practice hand hygiene and don appropriate PPE according to infection control guidelines to avoid the...
875
Suctioning the Nasopharyngeal Airway01:29

Suctioning the Nasopharyngeal Airway

3.2K
Nasopharyngeal suctioning is a procedure to remove secretions from the upper part of the respiratory tract that the patient cannot clear independently. It helps maintain airway patency and prevents complications such as aspiration pneumonia.
Equipment Required
3.2K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

214
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

276
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
276
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

203
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
203
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

262
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
262

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pediatric Non-Cystic Fibrosis Pulmonary Nontuberculous Mycobacterium Infections: A Global Population Based Study.

Pediatric health, medicine and therapeutics·2025
Same author

Therapeutic Management Strategies Among Immunocompetent Infants with Nontuberculous Mycobacterial Pulmonary Infection.

Pediatric health, medicine and therapeutics·2025
Same author

Complex pathways leading to future paediatric asthma exacerbations.

ERJ open research·2022
Same author

Pediatric Coronavirus Disease 2019 and Radiographic Screening: Identification of Patients at Risk.

Pediatric allergy, immunology, and pulmonology·2022
Same author

Pulmonary Nontuberculous Mycobacterial Infection in Infants: A Systematic Review.

Pediatric health, medicine and therapeutics·2022
Same author

Pediatric Vaccine Hesitancy and the Utilization of Antibody Measurements: A Novel Strategy with Implications for COVID 19.

Journal of asthma and allergy·2021

Related Experiment Video

Updated: Jan 26, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

18.5K

Airway Malformations and Bronchiectasis: A Pediatric Study.

Amrita Dosanjh1

  • 1Pediatric Respiratory, San Diego, CA, USA.

Ear, Nose, & Throat Journal
|April 13, 2019
PubMed
Summary

Congenital airway malformations rarely lead to bronchiectasis in children. This study found a low coexistence, suggesting effective preventative treatments for respiratory infections in pediatric patients with airway anomalies.

Area of Science:

  • Pediatric Pulmonology
  • Medical Informatics

Background:

  • Congenital airway malformations are typically diagnosed in early childhood.
  • Bronchiectasis development alongside lower airway malformations is documented, primarily in adults.
  • The co-occurrence of these conditions in pediatric populations is not well-established.

Purpose of the Study:

  • To investigate the frequency of bronchiectasis in pediatric patients with congenital airway malformations.
  • To determine if younger patients with airway anomalies commonly develop bronchiectasis.

Main Methods:

  • Defined International Classification of Diseases, Ninth Revision (ICD-9) codes for airway anomalies and bronchiectasis.
  • Searched a children's hospital electronic medical records system for patients with airway anomalies.

More Related Videos

A Patient-Derived Xenograft Model for Venous Malformation
06:51

A Patient-Derived Xenograft Model for Venous Malformation

Published on: June 15, 2020

5.8K
Studying Wnt Signaling During Patterning of Conducting Airways
13:00

Studying Wnt Signaling During Patterning of Conducting Airways

Published on: October 16, 2016

7.8K

Related Experiment Videos

Last Updated: Jan 26, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

18.5K
A Patient-Derived Xenograft Model for Venous Malformation
06:51

A Patient-Derived Xenograft Model for Venous Malformation

Published on: June 15, 2020

5.8K
Studying Wnt Signaling During Patterning of Conducting Airways
13:00

Studying Wnt Signaling During Patterning of Conducting Airways

Published on: October 16, 2016

7.8K
  • Cross-referenced airway database with ICD codes for bronchiectasis to identify co-occurring cases.

    • Main Results:

    • Out of 844 patients with airway anomalies and 117 with bronchiectasis (August 2009-September 2014), only 3 patients had both conditions.
    • The coexistence of bronchiectasis was found to be low in the studied pediatric population with upper airway anomalies.

    Conclusions:

    • The low incidence suggests current management strategies are effective in preventing recurrent lower respiratory tract infections in children with airway anomalies.
    • Further research is recommended to evaluate strategies for preventing aspiration and lower respiratory tract infections.
    • Database integration platforms are valuable for identifying pediatric patient cohorts for further study.